Drug Profile
Research programme: psoriasis therapies - SIDR
Alternative Names: Psoriasis therapies research programme - SIDRLatest Information Update: 05 Feb 2008
Price :
$50
*
At a glance
- Originator Strathclyde Institute for Drug Research
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psoriasis
Most Recent Events
- 05 Feb 2008 No development reported - Preclinical for Psoriasis in South Africa (unspecified route)
- 05 Feb 2008 No development reported - Preclinical for Psoriasis in United Kingdom (unspecified route)
- 28 Nov 2002 This research programme is available for licensing (http://www.sidr.org)